FTC's Amgen-Horizon Protest Raises Conglomerate Concerns
By Hartmut Schneider, Dominic Vote and Leon Greenfield · June 21, 2023, 1:54 PM EDT
The Federal Trade Commission's recent complaint in the U.S. District Court for the Northern District of Illinois seeking to enjoin the closing of Amgen Inc.'s proposed $28 billion acquisition of Horizon Therapeutics...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login